Navigation Links
USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic
Date:7/7/2009

LOS ANGELES, July 7 /PRNewswire-USNewswire/ -- The University of Southern California today announced that Dr. Alan Epstein of the USC Keck School of Medicine has received approval for a $3.5 million drug development project through the Rapid Access to Intervention Development (RAID) program of the National Cancer Institute (NCI) for his breakthrough Interleukin-2 (IL-2) cytokine immunotherapy analog. This is the second RAID award Dr. Epstein has received from the National Cancer Institute.

The NCI RAID program is a peer-reviewed competitive award program designed to assist translation of novel anticancer therapeutics to the clinic. The goal of the program is to show proof of principle that a new molecule is a viable candidate for expanded clinical evaluation. As a RAID award recipient, Dr. Epstein will receive access to drug development resources of the Developmental Therapeutics Program. These resources will be used to further the preclinical development of his IL-2 analog therapy for the treatment of certain cancers that appears to retain the benefits of existing IL-2 therapies without the major side effects that currently limit their application.

IL-2 cytokine immunotherapy is used to treat metastatic melanoma and metastatic renal cell carcinoma, diseases that afflict over 60,000 and 50,000 people in the United States each year, respectively. An increase in melanoma incidence has elevated the disease to the sixth most common cancer in the United States. Approximately 60,000 Americans developed invasive cutaneous melanoma in 2007, with an estimated additional 48,000 or more cases of melanoma in situ. The current lifetime risk for developing invasive melanoma is 1 case per 60 Americans. Currently, IL-2 is the only FDA approved immunotherapeutic agent.

But while the current therapy provides unparalleled recovery for certain cancer patients, the application of IL-2 is severely li
'/>"/>

SOURCE University of Southern California
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
5. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
6. An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R)
7. Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School
8. YouthAIDS, Levis and BETs Rap It-Up Campaign Kick Off 2007 Kick Me Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country
9. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
10. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
11. Study Findings Show Infection Control Intervention Helps Keep Kids in School

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...-- Facet Solutions, Inc. announced today that it h...s. The acquisition creates an undisputed leadershi...erty and clinical experience in posterior motion p... from lumbar spinal stenosis," stated Facet Soluti...olidation further strengthens Facet Solutions, pos...
(Date:11/6/2009)...tCall/ -- Boston Scientific Corporation (NYSE: BS...nt in principle with the U.S. Department of Justic...s Guidant subsidiary in 2005. The alleged conduct...ific,s 2006 acquisition of Guidant. ,, Boston S...n by the U.S. Attorney,s Office in Minneapolis int...
(Date:11/6/2009)...-- Philips Respironics applauds the efforts of the...to raise awareness about an important public healt...release of the first-ever government study to moni... a milestone in quantifying the size and scope of ...try leader and sleep therapy manufacturer, Philips...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Promising device snags young inventors coveted spot at IShow 8813 1Promising device snags young inventors coveted spot at IShow 8813 2Promising device snags young inventors coveted spot at IShow 8813 3Cogdell Spencer Inc Declares Quarterly Dividend 48744 1Cogdell Spencer Inc Declares Quarterly Dividend 48744 2New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 1New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 2New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 3New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 4New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 5
...Nasdaq: MITI ), a biopharmaceutical company devel..., inflammation and autoimmune diseases, today,pres...ation for Cancer,Research (AACR) in San Diego, CA,...ies targeting CD33 and MCSP, for the treatment of .... BiTE antibodies are designed to direct,the body,...
...t,the Texas Heart Institute (THI) at St. Luke,s Ep...ld,s first clinical trial to treat heart attack,pa... better healing and to,prevent congestive heart fa...rt attack., Almost six million Americans have con...ovascular disease that inhibits the heart from,pum...
Other Medicine Technology:Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 2Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 4Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 5Texas Heart(R) Institute at St. Luke's Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type 2Texas Heart(R) Institute at St. Luke's Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type 3
(Date:11/7/2009)...wire/ -- Karen Ignagni, President and CEO of Ameri...ollowing statement today on House passage of H.R. ...ensive health care reform, and we have contributed...ul of how health insurance is provided. Earlier th...ion of pre-existing condition exclusions, no longe...
(Date:11/7/2009)...re/ -- The American Medical Association (AMA) toda...ship and Community Service to Manus C. Kraff, M.D....ecognizes physicians who have gone above and beyon...anding public service contribution to their local ...ng the opening session of the 2009 Interim Meeting...
(Date:11/7/2009)...Cook (GA), Louis J. Goodman (TX), Palmer P. Jones ... Nov. 7 The American Me...al society executive leaders with achievement awar...deals of the medical profession. The awards were p...eting in Houston. ,, (Logo: http://www.newsc...
(Date:11/7/2009)...e/ -- Members of the AMA are trying a last-minute ...ding the AMA,s support of HR 3962. ,, "We want... their PATIENTS, not the leadership of the AMA," s...ociation of American Physicians and Surgeons, and ...roups. ,, "If the AMA leadership ignores the p...
(Date:11/7/2009)...esponsibility to vigorously oppose abortion in hea...SHINGTON, Nov. 7 Ame...he following statement on the news that Cardinal J...ffordable Health Care for America Act (H.R. 3962),...or abortion is voted upon. ,, "Our Catholic bi...
Breaking Medicine News(10 mins):Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
...te heart disease in patients over age 65, accordin...cer Institute. // ADT is one of the most comm... results were based on data from CaPSURE, a nation...d weigh the benefits of androgen deprivation thera...
...t is a strong genetic predictor of colorectal canc...ng or cancer screening. //According to a recent st...ounseling and screening rates could be improved if... with a history of familial adenomatous polyposis,...
...rove movement in a mouse model of spinal muscular ...ied out at the NIH’s National// Institute of Neuro...t similar drugs might one day be useful for treati... NINDS, who helped lead the new study. The finding...
...infant mortality rates in Florida is widening, Flo...enate// committee on Wednesday, the Tallahassee De...field of Florida's Health and Family Health Servic...n Florida than white women," Sappenfield said, add...
...are calling on the Federal Government to fund a ne... stomach bugs. Rotavirus puts 10,000 Austral... turning up at hospital emergency wards and at doc...lable by private prescription at a cost of up to $...
...tinue to be "alarmingly dismal" with over 180 mill...ntres// to diagnose their diseases, says an indust...ealth and family welfare centres need to be set up...M). In India, currently, 1083 urban family w...
Other Medicine News:Health News:Benefits of ADT Against Risk of Heart Ailments 2Health News:Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy 2Health News:Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy 3Health News:Call for Rotavirus Vaccine Funding 2Health News:Urban Poor in Dire Need of Proper Healthcare: Report 2
...nce and Defiance III is DonJoy's hallmark knee bra...s and design, this lightweight brace provides dura...nd LCL instabilities. Plus, the low-profile design...niforms, including hockey and football. As the str...
Marathon Strap-Lock Post-Op Knee
Controlled Dynamic Stretch Knee Brace
Bledsoe Cage Knee Brace
Medicine Products: